scispace - formally typeset
J

Jun Zheng

Researcher at Sun Yat-sen University

Publications -  22
Citations -  868

Jun Zheng is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Mesenchymal stem cell & Reperfusion injury. The author has an hindex of 10, co-authored 22 publications receiving 426 citations.

Papers
More filters
Journal ArticleDOI

Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.

TL;DR: The pooled outcomes revealed that a high NLR before treatment predicted a poor OS and poor RFS for patients with HCC, and both the NLR and PLR may be considered as reliable and inexpensive biomarkers for making clinical decisions regarding HCC treatment.
Journal ArticleDOI

A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer.

TL;DR: It is found that circFNDC3B-218aa inhibited the expression of Snail, and subsequently promoted the tumor-suppressive effect of FBP1 in CC.
Journal ArticleDOI

Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response

TL;DR: It is demonstrated that human umbilical cord MSC‐ EVs (huc‐MSC‐EVs) could protect against IRI‐induced hepatic apoptosis by reducing the infiltration of neutrophils and alleviating oxidative stress in hepatic tissue in vivo.
Journal ArticleDOI

MSCs ameliorate hepatocellular apoptosis mediated by PINK1-dependent mitophagy in liver ischemia/reperfusion injury through AMPKα activation

TL;DR: A novel pharmacological mechanism is provided that MSCs exert hepatoprotective effect in liver I/R injury via upregulating PINK1-dependent mitophagy through modulation of AMPKα activation.
Journal ArticleDOI

Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.

TL;DR: Preoperative SII may be a powerful prognostic biomarker in patients with HCC who undergo LT within the Hangzhou criteria and is superior to PLR, NLR, and MLR for prediction of OS in these patients.